Total Payments
$305.61
2023 Payments
$56.35
Companies
5
Transactions
12
Medicare Patients
605
Medicare Billing
$293,518
Payment Breakdown by Category
Food & Beverage$305.61 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $305.61 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ORGANOGENESIS INC. | $124.18 | 3 | $0 (2020) |
| Allergan, Inc. | $85.48 | 5 | $0 (2020) |
| Tactile Systems Technology Inc | $56.35 | 2 | $0 (2023) |
| Smith+Nephew, Inc. | $24.92 | 1 | $0 (2020) |
| Pacira Pharmaceuticals Incorporated | $14.68 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $56.35 | 2 | Tactile Systems Technology Inc ($56.35) |
| 2021 | $14.68 | 1 | Pacira Pharmaceuticals Incorporated ($14.68) |
| 2020 | $139.79 | 6 | ORGANOGENESIS INC. ($63.90) |
| 2019 | $60.28 | 1 | Organogenesis Inc. ($60.28) |
| 2017 | $34.51 | 2 | Allergan Inc. ($34.51) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/02/2023 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $33.21 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 09/27/2023 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 03/04/2021 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Pain Management | ||||||
| 07/06/2020 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $18.06 | General |
| 06/04/2020 | Allergan, Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/05/2020 | ORGANOGENESIS INC. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $39.57 | General |
| Category: Wound Care | ||||||
| 03/04/2020 | Allergan, Inc. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/10/2020 | ORGANOGENESIS INC. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $24.33 | General |
| Category: Wound Care | ||||||
| 01/13/2020 | Smith+Nephew, Inc. | Santyl (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Pharma Product | ||||||
| 11/19/2019 | Organogenesis Inc. | Apligraf (Device) | Food and Beverage | Cash or cash equivalent | $60.28 | General |
| Category: Wound Care | ||||||
| 12/20/2017 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/01/2017 | Allergan Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 266 | 616 | $701,777 | $268,228 |
| 2022 | 2 | 70 | 72 | $13,200 | $6,095 |
| 2021 | 4 | 72 | 104 | $14,275 | $5,034 |
| 2020 | 6 | 197 | 309 | $37,096 | $14,161 |
Total Patients
605
Total Services
1,101
Medicare Billing
$293,518
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36482 | Chemical destruction of first incompetent vein of arm or leg using imaging guidance | Office | 2023 | 25 | 80 | $301,584 | $114,386 | 37.9% |
| 36465 | Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | Office | 2023 | 26 | 94 | $275,930 | $105,140 | 38.1% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 37 | 126 | $32,486 | $12,819 | 39.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 44 | 108 | $28,841 | $11,492 | 39.8% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 37 | 52 | $21,375 | $8,357 | 39.1% |
| 36471 | Injection of chemical agent into multiple incompetent veins of leg | Office | 2023 | 26 | 47 | $20,740 | $8,186 | 39.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $8,489 | $2,962 | 34.9% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 27 | 55 | $6,872 | $2,732 | 39.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 28 | $5,459 | $2,153 | 39.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 58 | 60 | $10,200 | $4,739 | 46.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $3,000 | $1,356 | 45.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 35 | 62 | $4,444 | $2,530 | 56.9% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 11 | 11 | $7,700 | $1,115 | 14.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 13 | 18 | $1,554 | $1,103 | 71.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 13 | 13 | $577.00 | $286.80 | 49.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 96 | 196 | $15,571 | $7,403 | 47.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 24 | 24 | $3,448 | $1,888 | 54.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 24 | 31 | $3,476 | $1,769 | 50.9% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 14 | 16 | $11,200 | $1,635 | 14.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 28 | 28 | $2,212 | $1,186 | 53.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Facility | 2020 | 11 | 14 | $1,190 | $280.30 | 23.6% |
About Dr. Shannon Davis, DO
Dr. Shannon Davis, DO is a Phlebology healthcare provider based in Orland Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1215059506.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shannon Davis, DO has received a total of $305.61 in payments from pharmaceutical and medical device companies, with $56.35 received in 2023. These payments were reported across 12 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($305.61).
As a Medicare-enrolled provider, Davis has provided services to 605 Medicare beneficiaries, totaling 1,101 services with total Medicare billing of $293,518. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Phlebology
- Other Specialties Surgery, Surgery
- Location Orland Park, IL
- Active Since 04/06/2007
- Last Updated 02/15/2025
- Taxonomy Code 202K00000X
- Entity Type Individual
- NPI Number 1215059506
Products in Payments
- Puraply (Medical Supply) $63.90
- Apligraf (Device) $60.28
- Flexitouch Plus (Device) $56.35
- Santyl (Drug) $24.92
- AVYCAZ (Drug) $21.83
- DALVANCE (Drug) $17.43
- TEFLARO (Drug) $15.48
- Exparel (Drug) $14.68
- VIBERZI (Drug) $12.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.